Viewing Study NCT05631704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2026-02-10 @ 1:04 AM
Study NCT ID: NCT05631704
Status: UNKNOWN
Last Update Posted: 2023-01-13
First Post: 2022-11-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate Safety, Tolerability, and Pharmacokinetics (PK) of VH4524184 and the Potential for Changes in Cytochrome P450 3A (CYP3A) Activity
Sponsor: ViiV Healthcare
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None First-time-in-human View
None GSK4524184 View
None Healthy volunteers View
None Multiple Ascending Dose View
None Single Ascending Dose View
None VH4524184 View